Disorders of platelet function abnormalities of the platelet P2 receptors

Pathophysiology of Haemostasis and Thrombosis

Volumn 35, Issue 1-2, 2006, Pages

  Cattaneo, Marco ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DESMOPRESSIN; PURINE P2 RECEPTOR; PURINE P2Y1 RECEPTOR; PURINE P2Y12 RECEPTOR; THROMBOCYTE RECEPTOR;

CONFERENCE PAPER; CONGENITAL DISORDER; DIAGNOSTIC TEST; DISEASE SEVERITY; DRUG EFFECT; HETEROZYGOSITY; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; THROMBOCYTE DYSFUNCTION; THROMBOCYTE FUNCTION;

EID: 33748453567     PISSN: 14248832     EISSN: None     Source Type: Journal    
DOI: 10.1159/000093537     Document Type: Conference Paper

References (42)

1. Abbracchio, MP; Boeynaems, J-M; Barnard, EA.; Boyer, JL.; Kennedy, C; Characterization of the UDP-glucose receptor (re-named the P2Y14 receptor) adds diversity to the P2Y receptor family. Trends Pharmacol Sci 2003;24:52-55
2. Boeynaems J-M, Communi D, Suarez Gonzales N, Robaye B. Overview of the P2 receptors. Sem Thromb Hemost 2005;31:139-149.
3. Abbracchio, MP, Burnstock G, Boeynaems JM, Barnard EA, Boyer JM, Kennedy C, et al. The recently deophanized GPR80 (GPR99) proposed to be the P2Y15 receptor is not a genuine P2Y receptor. Trend Pharmacol Sci 2005;26:8-9
4. Wang L, Ostberg O, Wihlborg AK, Brogren H, Jern S, Erlinge D. Quantification of ADP and ATP receptor expression in human platelets. J Thromb Haemost. 2003 Feb;1(2):330-6.
5. Huang EM, Detwiler TC. Stimulus-response coupling mechanisms. In: Biochemistry of Platelets, DR Phillips and MA Shuman eds. Academic Press, Inc.Orlando, FL. 1986, pp1-68.
6. Falcon CR, Cattaneo M, Ghidoni A, Mannucci PM. The in vitro production of thromboxane B2 by platelets of diabetic patients is normal at physiological concentrations of ionised calcium. Thromb Haemost. 1993; 70:389-392.
7. Mustard JF, Perry DW, Kinlough-Rathbone RL, Packham MA. Factors responsible for ADP-induced release reaction of human platelets. Am J Physiol. 1975; 228:1757-1765.
8. Packham MA, Mustard JF. Platelet aggregation and adenosine diphosphate/adenosine triphosphate receptors: a historical perspective. Sem Thromb Hemost 2005; 31:129-138.
9. Cattaneo M, Gachet C, Cazenave J-P, Packham MA. Adenosine diphosphate (ADP) does not induce thromboxane A2 generation in human platelets. Blood. 99(10):3868-3869, 2002.
10. Cattaneo M, Gachet C. ADP receptors and clinical bleeding disorders. Arteriosclerosis, Thrombosis and Vascular Biology 19:2281-2285, 1999.
11. Jin J, Kunapuli SP. Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation. Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8070-4.
12. Leon C, Vial C, Gachet C, Ohlmann P, Hechler B, Cazenave JP, Lecchi A, Cattaneo M. The P2Y1 receptor is normal in a patient presenting a severe deficiency of ADP-induced platelet aggregation. Thromb Haemost. 1999 May;81(5):775-81.
13. Leon C, Hechler B, Freund M, Eckly A, Vial C, Ohlmann P, Dierich A, LeMeur M, Cazenave JP, Gachet C. Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null mice. J Clin Invest. 1999 Dec;104(12):1731-7.
14. Fabre JE, Nguyen M, Latour A, Keifer JA, Audoly LP, Coffman TM, Koller BH. Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice. Nat Med. 1999 Oct;5(10):1199-202.
15. Mustard JF, Packham MA. Factors influencing platelet function: adhesion, release and aggregation. Pharmacol Rev 1970;22:97-187.
16. MacFarlane DE, Mills DC. The effects of ATP on platelets: evidence against the central role of released ADP in platelet aggregation. Blood 1975; 46:309-320.
17. Rolf MG, Brearley CA, Mahaut-Smith MP. Platelet shape change evoked by selective activation of P2X1 purinoceptors with alpha,beta-methylene ATP. Thromb Haemost. 2001 Feb;85(2):303-8.
18. Cattaneo M, Marchese P, Jacobson KA and Ruggeri Z (2002) New insights into the role of P2X1 in platelet function (abstract). Haematologica 87:13-14.
19. Cattaneo M, Marchese P, Jacobson KA, Ruggeri ZM. The P2X1 receptor for ATP plays an essential role in platelet aggregation at high shear. Haematology J 2003;4(suppl 2):150 (abstract).
20. Oury C, Toth-Zsamboki E, Thys C, Tytgat J, Vermylen J, Hoylaerts MF. The ATP-gated P2X1 ion channel acts as a positive regulator of platelet responses to collagen. Thromb Haemost. 2001 Nov;86(5):1264-71.
21. Oury C, Sticker E, Cornelissen H, De Vos R, Vermylen J, Hoylaerts MF. ATP augments von Willebrand factor-dependent shear-induced platelet aggregation through Ca2+-calmodulin and myosin light chain kinase activation. J Biol Chem. 2004 Jun 18;279(25):26266-73.
22. Beukers MW, Pirovano IM, van Weert A, Kerkhof CJ, IJzerman AP, Soudijn W. Characterization of ecto-ATPase on human blood cells. A physiological role in platelet aggregation? Biochem Pharmacol. 1993 Dec 3;46(11):1959-66.
23. Enjyoji K, Sevigny J, Lin Y, Frenette PS, Christie PD, Esch JS 2nd, Imai M, Edelberg JM, Rayburn H, Lech M, Beeler DL, Csizmadia E, Wagner DD, Robson SC, Rosenberg RD. Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat Med. 1999 Sep;5(9):1010-7.
24. Marcus AJ, Broekman MJ, Drosopoulos JHF, Olson KE, Islam N, Pinsky DJ, Levi R. Role of CD39 (NTPDase-1) in thromboregulation, cerebroprotection, and cardioprotection. Sem Thromb Hemost 2005;31:234-246.
25. Robson SC, Wu, Y, Sun X, Knosalla C, Dwyer K, Eniyoji K. Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis an transplantation. Sem Thromb Hemost 2005;31:217-233.
26. Oury C, Lenaerts T, Peerlinck K, Vermylen J, Hoylaerts MF. Congenital deficiency of the phospholipase C coupled platelet P2Y1 receptor leads to a mild bleeding disorder. Thromb Haemost 1999;85(suppl):20 (abs.)
27. Cattaneo M, Lecchi A, Randi AM, McGregor JL, Mannucci PM. Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate. Blood. 1992; 80:2787-96.
28. Gachet C, Cattaneo M, Ohlmann P, Hechler B, Lecchi A, Chevalier J, Cassel D, Mannucci PM, Cazenave JP. Purinoceptors on blood platelets: further pharmacological and clinical evidence to suggest the presence of two ADP receptors. Br J Haematol. 1995 Oct;91(2):434-44.
29. Gachet C. The platelet P2 receptors as molecular targets for old and new antiplatelet drugs. Pharmacol Therapeut 2005;108:180-192.
30. Nurden P, Savi P, Heilmann E, Bihour C, Herbert JM, Maffrand JP and Nurden A (1995) An inherited bleeding disorder linked to a defective interaction between ADP and its receptor on platelets. Its influence on glycoprotein IIb-IIIa complex function. J Clin Invest 95:1612-22.
31. Cattaneo M, Lecchi A, Lombardi R, Gachet C, Zighetti ML. Platelets from a patient heterozygous for the defect of P2CYC receptors for ADP have a secretion defect despite normal thromboxane A2 production and normal granule stores: further evidence that some cases of platelet 'primary secretion defect' are heterozygous for a defect of P2CYC receptors. Arterioscler Thromb Vasc Biol. 2000 Nov;20(11):E101-6.
32. Shiraga M, Miyata S, Kato H, Kashiwagi H, Honda S, Kurata Y, Tomiyama Y, Kanakura Y. Impaired platelet function in a patients with P2Y12 deficiency caused by a mutation in the translation initiation codon. J Thromb Haemost 2005;3:2315-2323.
33. Conley PB, Jurek MM, Vincent D, Lecchi A, Cattaneo M. Unique mutations in the P2Y12 locus of patients with previously described defects in ADP-dependent aggregation. Blood 2001; 98(11):43b
34. Hollopeter G, Jantzen HM, Vincent D, Li G, England L, Ramakrishnan V, Yang RB, Nurdeu P, Nurden A, Julius D, Conley PB. Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature. 2001 Jan 11;409(6817):202-7.
35. Cattaneo M. Inherited platelet-based bleeding disorders. J Thromb Haemost. 2003 Jul;1(7):1628-36.
36. Cattaneo M, Lombardi R, Zighetti ML, Gachet C, Ohlmann P, Cazenave J-P, Mannucci PM. Deficiency of [33P]2MeS-ADP binding sites on platelets with secretion defect, normal granule stores and normal thromboxane A2 production. Evidence that ADP potentiates platelet secretion independently of the formation of large platelet aggregates and thromboxane A2 production. Thromb Haemost. 1997; 77: 986-990.
37. Cattaneo M, Zighetti ML, Lombardi R, Martinez C, Lecchi A, Conley PB, Ware J and Ruggeri ZM (2003) Molecular bases of defective signal transduction in the platelet P2Y12 receptor of a patient with congenital bleeding. Proc Natl Acad Sci U S A 100:1978-83.
38. Moro S, Hoffmann C, Jacobson KA. Role of the extracellular loops of G protein-coupled receptors in ligand recognition: a molecular modeling study of the human P2Y1 receptor. Biochemistry 1999; 38(12):3498-3507.
39. Moro S, Guo D, Camaioni E, Boyer JL, Harden TK, Jacobson KA. Human P2Y1 receptor: molecular modeling and site-directed mutagenesis as tools to identify agonist and antagonist recognition sites. J Med Chem 1998; 41(9):1456-1466.
40. Schwarz UR, Geiger J, Walter U and Eigenthaler M (1999) Flow cytometry analysis of intracellular VASP phosphorylation for the assessment of activating and inhibitory signal transduction pathways in human platelets - definition and detection of ticlopidine/clopidogrel effects. Thromb Haemost 82:1145-52
41. Cattaneo M, Zighetti ML, Lombardi R, Mannucci PM. Role of ADP in platelet aggregation at high shear: studies in a patient with congenital defect of platelet responses to ADP. Br J Haematol. 1994; 88: 826-829.
42. Oury C, Toth-Zsamboki E, Van Geet C, Thys C, Wei L, Nilius B et al. A natural dominant negative P2X1 receptor due to deletion of a single amino acid residue. J Biol Chem 2000; 275(30):22611-22614.